Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 053458/0928 | |
| Pages: | 4 |
| | Recorded: | 08/11/2020 | | |
| Attorney Dkt #: | 10915/006906-US0 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16066851
|
Filing Dt:
|
06/28/2018
|
|
Publication #:
|
|
Pub Dt:
|
01/10/2019
| | | | |
|
Title:
|
PHARMACEUTICAL COMPOSITION FOR TREATING CANCER AND SUPPRESSING METASTASIS, CONTAINING SULFONAMIDE-BASED COMPOUND AS ACTIVE INGREDIENT
|
|
|
Assignee
|
|
|
|
|
| (SA-DONG, BUSINESS INCUBATION CENTER) 55, HANYANGDAEHAK-RO, SANGROK-GU ANSAN-SI |
| GYEONGGI-DO, KOREA, REPUBLIC OF 15588 |
|
|
Correspondence name and address
|
| |
LEASON ELLIS LLP
|
| |
ONE BARKER AVENUE
|
| |
FIFTH FLOOR
|
| |
WHITE PLAINS, NY 106011523
|
Search Results as of:
09/21/2024 06:02 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
